Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.19.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Total revenues $ 12,624  
Costs and expenses:    
Cost of product sales 107  
Research and development 10,949 $ 11,242
Selling, general and administrative 19,946 13,492
Total costs and expenses 31,002 24,734
Loss from operations (18,378) (24,734)
Interest income 780 349
Net loss $ (17,598) $ (24,385)
Net loss per share, basic and diluted (in dollars per share) $ (0.11) $ (0.17)
Weighted average shares used in computing net loss per share, basic and diluted (in shares) 167,173 147,114
Product sales, net    
Total revenues $ 8,054  
Contract revenues from collaborations    
Total revenues $ 4,570